LongueVue Capital Invests in Summit Clinical Research
October 26, 2022
LongueVue Capital completed a growth investment in Summit Clinical Research, an integrated research organization (IRO) headquartered in San Antonio, Texas. The investment will provide financial and human capital to accelerate Summit's growth and expand its clinical trial site network and capabilities, particularly in hepatology and NASH research.
- Buyers
- LongueVue Capital
- Targets
- Summit Clinical Research, LLC
- Industry
- Healthcare Services
- Location
- Texas, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
LongueVue Capital Invests in Pinnacle Clinical Research
November 16, 2022
Healthcare Services
LongueVue Capital, a New Orleans-based private equity firm, completed a growth investment in Pinnacle Clinical Research, a San Antonio-based multi-location clinical trial site network specializing in complex therapeutic areas including hepatology (NAFLD/NASH). The capital from LVC is intended to support Pinnacle’s organic and inorganic growth, expand clinical trial capacity, and enhance operational capabilities across its Texas sites.
-
Summit Clinical Research (with Pinnacle) Acquires Houston Research Institute
February 28, 2025
Healthcare Services
LongueVue Capital portfolio company Summit Clinical Research, in partnership with Pinnacle Clinical Research, completed a strategic investment in Houston Research Institute (HRI) to expand Summit's metabolic/hepatology clinical research capabilities. The transaction brings HRI's scientific expertise into Summit/Pinnacle's site network and is accompanied by leadership additions — Dr. Mazen Noureddin named Co-Chairman (and Chief Scientific Officer), Dr. Naim Alkhouri as Chief Academic Officer, and Brandon Early as President.
-
Pinnacle Clinical Research (LongueVue Capital) Combines with South Texas Research Institute
January 10, 2023
Healthcare Services
Pinnacle Clinical Research, a LongueVue Capital portfolio company, has completed a combination with South Texas Research Institute (STRI). The deal expands Pinnacle's clinical site network to six dedicated locations, strengthens recruitment capabilities (notably for NASH/NAFLD trials) and increases geographic reach into the Rio Grande Valley.
-
LongueVue Capital Recapitalizes Summit Plastics
January 20, 2021
Packaging
New Orleans-based private equity firm LongueVue Capital has completed a recapitalization and growth investment in Summit Plastics, partnering with CEO Tom Nathanson and the company's management team. Summit Plastics, headquartered in Summit, Mississippi, is a niche B2B manufacturer of custom LLDPE blown film and bags serving food & beverage, industrial, and healthcare end markets; Origin Bank provided senior debt for the transaction.
-
Summit Partners Makes Majority Growth Investment in LumaBridge
August 23, 2022
Healthcare Services
Summit Partners has made a majority growth equity investment in LumaBridge, an oncology-focused clinical research organization (CRO) headquartered in San Antonio, Texas. The capital will support LumaBridge’s expansion of clinical trial capabilities and enable the company to serve a larger number of emerging biopharma sponsors developing immuno-oncology therapies.
-
Pinnacle Clinical Research Acquires Jubilee Clinical Research
September 27, 2024
Healthcare Services
LongueVue Capital-backed Pinnacle Clinical Research has acquired Jubilee Clinical Research, a Las Vegas-based multi-therapeutic clinical trial site focused on metabolic and cardiovascular indications. The add-on expands Pinnacle's West Coast footprint and therapeutic expertise; Jubilee's founder Dr. Elliot Shin will continue to lead the site within the Pinnacle network.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.